The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2025
Synopsis
The global market for Pharmaceutical Grade Nicotinamide Mononucleotide was valued at US$ 542 million in the year 2024 and is projected to reach a revised size of US$ 673 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
North American market for Pharmaceutical Grade Nicotinamide Mononucleotide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Grade Nicotinamide Mononucleotide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, Bangtai Bio, Jindawei, Hongboyuan Life Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Nicotinamide Mononucleotide.
The Pharmaceutical Grade Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
by Type
Concentration≥98%
Concentration＜98%
by Application
Health Products
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Pharmaceutical Grade Nicotinamide Mononucleotide was valued at US$ 542 million in the year 2024 and is projected to reach a revised size of US$ 673 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
North American market for Pharmaceutical Grade Nicotinamide Mononucleotide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Grade Nicotinamide Mononucleotide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, Bangtai Bio, Jindawei, Hongboyuan Life Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Nicotinamide Mononucleotide.
The Pharmaceutical Grade Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
by Type
Concentration≥98%
Concentration＜98%
by Application
Health Products
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Nicotinamide Mononucleotide by Type
1.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Concentration≥98%
1.2.3 Concentration＜98%
1.3 Pharmaceutical Grade Nicotinamide Mononucleotide by Application
1.3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Health Products
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry
2.9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2026-2031)
3.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2026-2031)
3.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region
4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2020-2031)
5.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2020-2025)
5.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2026-2031)
5.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2020-2031)
6.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2020-2025)
6.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2026-2031)
6.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Application (2020-2031)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Shinkowa
7.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shinkowa Main Business and Markets Served
7.3.5 Shinkowa Recent Developments/Updates
7.4 EffePharm
7.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.4.4 EffePharm Main Business and Markets Served
7.4.5 EffePharm Recent Developments/Updates
7.5 Mirailab Bioscience
7.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Mirailab Bioscience Main Business and Markets Served
7.5.5 Mirailab Bioscience Recent Developments/Updates
7.6 Bangtai Bio
7.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Bangtai Bio Main Business and Markets Served
7.6.5 Bangtai Bio Recent Developments/Updates
7.7 Jindawei
7.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Jindawei Main Business and Markets Served
7.7.5 Jindawei Recent Developments/Updates
7.8 Hongboyuan Life Technology
7.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
7.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Hongboyuan Life Technology Main Business and Markets Served
7.8.5 Hongboyuan Life Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
8.2 Pharmaceutical Grade Nicotinamide Mononucleotide Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Nicotinamide Mononucleotide Production Mode & Process Analysis
8.4 Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Marketing
8.4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Sales Channels
8.4.2 Pharmaceutical Grade Nicotinamide Mononucleotide Distributors
8.5 Pharmaceutical Grade Nicotinamide Mononucleotide Customer Analysis
9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Dynamics
9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Trends
9.2 Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers
9.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
9.4 Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical Grade Nicotinamide Mononucleotide as of 2024)
Table 10. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application
Table 13. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry
Table 14. Global Pharmaceutical Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Region (2020-2025)
Table 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region (2020-2025)
Table 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share Forecast by Region (2026-2031)
Table 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025) & (Tons)
Table 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region (2020-2025)
Table 31. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)
Table 35. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)
Table 45. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2020-2025)
Table 46. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2026-2031)
Table 47. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2020-2025)
Table 48. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2026-2031)
Table 49. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2020-2025)
Table 52. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2026-2031)
Table 53. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2020-2025)
Table 54. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2026-2031)
Table 55. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2020-2025)
Table 56. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2026-2031)
Table 57. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2020-2025)
Table 58. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2026-2031)
Table 59. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2020-2025)
Table 62. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2026-2031)
Table 63. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2020-2025)
Table 64. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2026-2031)
Table 65. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 66. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 67. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. GeneHarbor Main Business and Markets Served
Table 69. GeneHarbor Recent Developments/Updates
Table 70. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 71. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 72. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Herbalmax Main Business and Markets Served
Table 74. Herbalmax Recent Developments/Updates
Table 75. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 76. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 77. Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Shinkowa Main Business and Markets Served
Table 79. Shinkowa Recent Developments/Updates
Table 80. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 81. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 82. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. EffePharm Main Business and Markets Served
Table 84. EffePharm Recent Developments/Updates
Table 85. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 86. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 87. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Mirailab Bioscience Main Business and Markets Served
Table 89. Mirailab Bioscience Recent Developments/Updates
Table 90. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 91. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 92. Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Bangtai Bio Main Business and Markets Served
Table 94. Bangtai Bio Recent Developments/Updates
Table 95. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 96. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 97. Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Jindawei Main Business and Markets Served
Table 99. Jindawei Recent Developments/Updates
Table 100. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Company Information
Table 101. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application
Table 102. Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Hongboyuan Life Technology Main Business and Markets Served
Table 104. Hongboyuan Life Technology Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Pharmaceutical Grade Nicotinamide Mononucleotide Distributors List
Table 108. Pharmaceutical Grade Nicotinamide Mononucleotide Customers List
Table 109. Pharmaceutical Grade Nicotinamide Mononucleotide Market Trends
Table 110. Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers
Table 111. Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
Table 112. Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Grade Nicotinamide Mononucleotide
Figure 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Type: 2024 VS 2031
Figure 4. Concentration≥98% Product Picture
Figure 5. Concentration＜98% Product Picture
Figure 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application: 2024 VS 2031
Figure 8. Health Products
Figure 9. Others
Figure 10. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) & (2020-2031)
Figure 12. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) & (2020-2031)
Figure 13. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) & (2020-2031)
Figure 14. Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (US$/Ton) & (2020-2031)
Figure 15. Pharmaceutical Grade Nicotinamide Mononucleotide Report Years Considered
Figure 16. Pharmaceutical Grade Nicotinamide Mononucleotide Production Share by Manufacturers in 2024
Figure 17. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Manufacturers (2024)
Figure 18. Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Nicotinamide Mononucleotide Revenue in 2024
Figure 20. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 30. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 31. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)
Figure 32. U.S. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 33. Canada Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 34. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)
Figure 36. Germany Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. France Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. U.K. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. Italy Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. Russia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region (2020-2031)
Figure 43. China Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. South Korea Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. China Taiwan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. Southeast Asia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. India Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)
Figure 51. Mexico Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Brazil Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Turkey Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. GCC Countries Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2020-2031)
Figure 56. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2020-2031)
Figure 57. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Type (2020-2031)
Figure 58. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2020-2031)
Figure 59. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2020-2031)
Figure 60. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Ton) by Application (2020-2031)
Figure 61. Pharmaceutical Grade Nicotinamide Mononucleotide Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
